Table 3.

Prevalence of medication use for chronic obstructive pulmonary disease and for comorbid diagnoses and symptoms among a national sample of patients with chronic obstructive pulmonary disease.

	Percent of COPD patients with condition taking medication*
	Women	Men	P-value
	N=581	N=422
Medication (any) for COPD (%)	74	69	0.10
Among patients without diagnosis of asthma	66	63	0.45
Among patients with diagnosis of asthma	79	79	0.89
Comorbid diagnoses
Medication (any) for hypertension* (%)	87	86	0.63
Statin for hypercholesterolemia* (%)	68	76	0.05
Medication (any) for depression* (%)	72	64	0.13
Medication (any) for osteoporosis* (%)	63	45	0.02
Continuous positive airway pressure for obstructive sleep apnea* (%)	48	45	0.57
Medication for diabetes mellitus* (%)
Insulin	28	44	0.01
Oral hypoglycemic	67	68	0.88
Medication for coronary artery disease* (%)
Aspirin	52	72	<0.001
Other cardiac medication	61	45	<0.001
Medication for stroke* (%)
Aspirin	50	67	0.07
Warfarin	34	38	0.64
Medication (any) for glaucoma* (%)	55	52	0.78
Comorbid symptoms
Medications for joint pain* (%)			<0.001
Prescription analgesic only	45	32
Over-the-counter analgesic only	19	17
Both	10	8
Regular medication (any) for heartburn or acid reflux* (%)	68	57	0.004
Medication (any; more than 1–2 times/year) for sinus problems* (%)	68	64	0.29

^*Among those reporting comorbid condition (the prevalence of comorbid conditions is listed in Table 2).